Treatment depends on the sarcoma’s type, location, grade, and stage, as well as the patient’s overall health and goals of care. Many patients benefit from a team approach that includes oncologists, ...

The FDA granted fast track status to ADCE-D01, a targeted drug in early trials for soft tissue sarcoma, to speed development ...

Adcendo ApS ("Adcendo"), a biotech company focused on the development of first and best-in-class antibody-drug conjugates ...

Blood-based biomarkers, including neutrophil-to-lymphocyte ratio and circulating tumor DNA, may improve treatment response ...

The fast track designation is supported by preclinical evidence of antitumor activity by ADCE-D01 in several STS tumor models ...

“Ewing sarcoma is part of this bigger group of cancers called sarcoma," Eward said. "What they all have in common is they ...

Raise money for a good cause and get a workout at the same time. Sarcoma survivor Jerry Glisch joins FOX6 WakeUp with more on how you can get involved in this year's Race to Cure Sarcoma. FOX viewers ...

A copy of the presentation materials can be accessed on the “Publication” section of the Company’s website at www.bioatla.com once the presentation has concluded.

A novel targeted radiation approach for a rare form of malignant tumor—the solitary fibrous tumor (SFT)—has shown significant success, achieving a near-complete response in three patients. The therapy ...